Johnson & Johnson to spend up to $750 million restructuring pharma manufacturing and closing plants
read at Endpoints ↗Neutral
Johnson & Johnson announced it will incur up to $750 million as it reshapes its pharmaceutical manufacturing network.
The plan involves exiting certain factories and consolidating production, aiming to streamline the supply chain.
The restructuring is part of the company's broader $55 billion commitment to transform its business, though the exact timeline and locations were not disclosed.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “J&J restructures pharma manufacturing footprint at cost of up to $750M”
read at Endpoints ↗82 words · retrieved Jul 15
comments(0)
5-min edit window · permanent after that